ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
US Tech 100
20,836.00
1.31%
Dow Jones
42,840.26
1.18%
Brent Oil
72.72
0.00%
Bitcoin
95,632.31
-1.62%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kezar Life Sciences Inc (KZR)

  7. Kezar Life Sciences Inc (KZR) News

KZR

Kezar Life Sciences (KZR)

Kezar Life Sciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KZR
DateTimeSourceHeadlineSymbolCompany
12/03/20244:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
11/12/20244:18PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KZRKezar Life Sciences Inc
11/12/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
11/12/20244:01PMBusiness WireKezar Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:KZRKezar Life Sciences Inc
10/29/20245:05PMEdgar (US Regulatory)Form 8-A12B/A - Registration of securities [Section 12(b)]: [Amend]NASDAQ:KZRKezar Life Sciences Inc
10/28/20244:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
10/28/20248:30AMBusiness WireKezar Life Sciences Announces 1-for-10 Reverse Stock SplitNASDAQ:KZRKezar Life Sciences Inc
10/17/20249:22AMEdgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:KZRKezar Life Sciences Inc
10/17/20248:47AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
10/17/20248:35AMBusiness WireKezar Board Unanimously Rejects Unsolicited Concentra Proposal and Adopts Limited Duration Stockholder Rights PlanNASDAQ:KZRKezar Life Sciences Inc
10/17/20248:30AMBusiness WireKezar Life Sciences Announces Positive IDMC Safety Review of PORTOLA Trial of Zetomipzomib in Patients with Autoimmune Hepatitis and Provides PALIZADE UpdateNASDAQ:KZRKezar Life Sciences Inc
10/10/20248:42AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
10/10/20248:30AMBusiness WireKezar Confirms Receipt of Unsolicited, Non-Binding Acquisition ProposalNASDAQ:KZRKezar Life Sciences Inc
10/04/20245:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
10/04/20245:00PMBusiness WireKezar Life Sciences Announces Clinical Hold of Zetomipzomib IND for Treatment of Lupus NephritisNASDAQ:KZRKezar Life Sciences Inc
09/30/20248:36AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
09/30/20248:30AMBusiness WireKezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis PatientsNASDAQ:KZRKezar Life Sciences Inc
09/04/20244:01PMBusiness WireKezar Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:KZRKezar Life Sciences Inc
08/13/20244:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KZRKezar Life Sciences Inc
08/13/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
08/13/20244:02PMBusiness WireKezar Life Sciences Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:KZRKezar Life Sciences Inc
07/26/20245:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KZRKezar Life Sciences Inc
07/10/20244:01PMBusiness WireKezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KZRKezar Life Sciences Inc
06/07/20245:59PMBusiness WireKezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KZRKezar Life Sciences Inc
06/04/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
05/29/20244:01PMBusiness WireKezar Life Sciences to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:KZRKezar Life Sciences Inc
05/09/20244:08PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KZRKezar Life Sciences Inc
05/09/20244:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KZRKezar Life Sciences Inc
05/09/20244:01PMBusiness WireKezar Life Sciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:KZRKezar Life Sciences Inc
05/06/20244:05PMBusiness WireKezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:KZRKezar Life Sciences Inc
 Showing the most relevant articles for your search:NASDAQ:KZR

Your Recent History

USOTC
AABB
Asia Broadband (PK)
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
AVXL
Anavex Life Sciences
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
NBRI
North Bay Resources (PK)
NASDAQ
COOP
Mr Cooper
USOTC
GVSI
Good Vibrations Shoes (PK)
NYSE
IONQ
IonQ
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
BIEL
Bioelectronics (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
FNMA
Fannie Mae (QB)
USOTC
RNVA
Rennova Health (CE)
USOTC
HMBL
HUMBL (PK)
USOTC
CGAC
Code Green Apparel (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads